NCT02492607 2026-01-26
LORD
The Netherlands Cancer Institute
Phase NA Active not recruiting
Clinical Trials
13 trialsNCT03878342 2026-01-23
ROMANCE
UNICANCER
Phase NA Active not recruiting
NCT02352883 2025-12-19
MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ
Eastern Cooperative Oncology Group
Phase NA Active not recruiting
NCT06961955 2025-12-09
FAST NOVEMBER
University of Utah
Phase 2 Recruiting
NCT01819233 2025-06-06
CAREFOR
Thomas Jefferson University
Phase NA Completed
NCT04176081 2024-01-24
SChLAP/IDC
University Health Network, Toronto
Phase 2 Not yet recruiting
NCT03437161 2023-02-17
A Prospective Trial to Compare Deep Inspiratory Breath Hold (DIBH) With Prone Breast Irradiation
NYU Langone Health
Phase NA Completed
NCT00003857 2022-05-25
Radiation Therapy With or Without Optional Tamoxifen in Treating Women With Ductal Carcinoma in Situ
Radiation Therapy Oncology Group
Phase 3 Completed
NCT01754519 2017-07-07
Radiation Therapy in Treating Post-Menopausal Women With Early Stage Breast Cancer Undergoing Surgery
Roswell Park Cancer Institute
Phase 2 Terminated
NCT00742222 2016-05-17
EXIBT
Xoft, Inc.
Phase 4 Completed
NCT00373191 2015-10-12
Effect of Surgery, Radiation Therapy, Chemotherapy, and Hormone Therapy on Biomarkers in Women With Stage I, Stage II, Stage III Breast Cancer, or Ductal Carcinoma In Situ That Can Be Removed By Surgery
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Completed
NCT00602628 2013-06-26
Radiation Therapy Planning Techniques in Reducing Damage to Normal Tissue in Women Undergoing Breast-Conserving Surgery for Ductal Carcinoma of the Breast
National Cancer Institute (NCI)
Phase NA Completed
NCT00077168 2009-02-09
Adjuvant Radiation Therapy Compared With Observation After Surgery in Treating Women With Estrogen Receptor Positive or Progesterone Receptor Positive Ductal Carcinoma In Situ of the Breast Who Are Receiving Tamoxifen or Anastrozole
National Cancer Institute (NCI)
Phase 2 Unknown